Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Irritable Bowel Syndrome, October 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 91 articles: HTML format

Single Articles

1. LIU Q, Ming Y, Ji C, Fu L, et al
   S100B in brain-gut-liver crosstalk: from glial activation to multiorgan inflammation.
   Front Immunol. 2026;17:1933882.
   PubMed    
   Abstract available
   
   

2. EL-CHAMMAS K, Hagenstein L, Chogle A, Santucci N, et al
   Functional Nausea Is Not Just Nausea: A Multi-Center, Cross-Sectional Study of Children and Young Adults.
   Neurogastroenterol Motil. 2026;38:e70447.
   PubMed    
   Abstract available
   
   

3. MIKHAEL-MOUSSA H, Aupetit A, Guerin O, Desprez C, et al
   When Food Avoidance Meets Compatible Diagnostic Criteria: Avoidant/Restrictive Food Intake Disorder Features in Irritable Bowel Syndrome.
   Neurogastroenterol Motil. 2026;38:e70456.
   PubMed    
   Abstract available
   
   

4. 
   Irritable bowel syndrome.
   Nat Rev Dis Primers. 2026;12:65.
   PubMed    
   
   
   

5. CHANG L, Corsetti M, Chey WD, Ford AC, et al
   Irritable bowel syndrome.
   Nat Rev Dis Primers. 2026;12:64.
   PubMed    
   Abstract available
   
   

6. VENKATARAMAN A, Midavaine E, Ingraham HA
   Sex-specific mechanisms of chronic pain.
   Science. 2026;394:69-74.
   PubMed    
   Abstract available
   
   

7. HUANG Z, Lyu Z, Liu F
   Exploring the psychogastroenterology patterns of functional dyspepsia and irritable bowel syndrome comorbidities based on latent profile analysis.
   Front Pharmacol. 2026;17:1759170.
   PubMed    
   Abstract available
   
   

8. TSAI FP, Chang LC, Tseng PH
   Reply to the comment on "Prevalence and clinical characteristics of irritable bowel syndrome in Taiwan: Rome III versus Rome IV criteria".
   J Formos Med Assoc. 2026 Sep 30:S0929-6646(26)00919.
   PubMed    
   
   
   

9. SOIFER LO, Contreras MV, Man F, Gonzalez-Florez A, et al
   Argentine consensus on the clinical utility of breath tests and small intestinal bacterial overgrowth management in patients with disorders of gut-brain interaction.
   Rev Gastroenterol Mex (Engl Ed). 2026 Sep 30:S2255-534X(26)00072.
   PubMed    
   Abstract available
   
   

10. YU A, Bi Y, Xu X
    Brain-Gut Axis Perspective on Irritable Bowel Syndrome: The Role of Gut Microbiota and Therapeutic Strategies of Traditional Chinese Medicine.
    Am J Chin Med. 2026 Sep 30:1-30. doi: 10.1142/S0192415X26500771.
    PubMed    
    Abstract available
    
    

11. WOELBER JP, Wirth N, Dallmer-Zerbe A, Tennert C, et al
    The oral und systemic health risks of sugar consumption: an umbrella review.
    Clin Oral Investig. 2026;30:490.
    PubMed    
    Abstract available
    
    

12. SUI Y, Li P, Yue X, Chen Y, et al
    Depressive symptoms as a mediator in the association between regular physical activity and irritable bowel syndrome-related symptom severity: a cross-sectional study among college students.
    Front Psychol. 2026;17:1856261.
    PubMed    
    Abstract available
    
    

13. FIROOZI M, Mahdavinezhad A, Shirzad M, Motevaseli E, et al
    Biotechnological Approaches to Probiotics and Postbiotics through the Gut-Brain Axis Modulation.
    Iran Biomed J. 2026;30:193-211.
    PubMed    
    Abstract available
    
    

14. WEI Q, Li L, Du Q, Zhang H, et al
    Bidirectional causal associations between Sjogren syndrome and gastrointestinal disorders: A two-sample Mendelian randomization study.
    Medicine (Baltimore). 2026;105:e50935.
    PubMed    
    Abstract available
    
    

15. RIZZO CE, Anza D, Genovese C, Sciacca D, et al
    Clinical and Public Health Lessons from a Point-Source Polymicrobial Foodborne Outbreak: Implications for Vaccination of Vulnerable Populations.
    Vaccines (Basel). 2026;14:804.
    PubMed    
    Abstract available
    
    

16. OGUTMEN KOC D, Sarbay I, Mercan Baspinar M, Mangal L, et al
    Orlistat-Associated Gastrointestinal, Hepatobiliary, Pancreatic, and Anorectal Safety Signals: A FAERS Disproportionality and Regulatory Label Concordance Study.
    Pharmaceuticals (Basel). 2026;19:1325.
    PubMed    
    Abstract available
    
    

17. TIMURKAAN ES, Timurkaan M, Yildiz S
    Cyberchondria, Psychological Well-Being, Anxiety, and Depression Levels in Female Patients with Irritable Bowel Syndrome.
    Medicina (Kaunas). 2026;62:1621.
    PubMed    
    Abstract available
    
    

18. LUU ATP, Vo TD
    Comparative Effectiveness of Mebeverine and Otilonium Bromide on Health-Related Quality of Life in Patients with Irritable Bowel Syndrome: A Prospective Cohort Study.
    Life (Basel). 2026;16:1390.
    PubMed    
    Abstract available
    
    

19. AKINCI GOKTAS O, Selbuz S
    Primary Headache Disorders in Pediatric Irritable Bowel Syndrome: Characterizing IBS-Associated Migraine Highlights.
    Children (Basel). 2026;13:1230.
    PubMed    
    Abstract available
    
    

20. BOICEA CAMEN AR, Caragea DC, Boldeanu MV, Florescu DN, et al
    Shift Work, Circadian Disruption, and Immune Dysregulation: Molecular Links to Gastrointestinal Diseases and Occupational Health Implications.
    Diagnostics (Basel). 2026;16:3010.
    PubMed    
    Abstract available
    
    

21. GABRIEL EM, Nooriankafshgari F, Garcia-Sierra R, Vallve CS, et al
    Irritable Bowel Syndrome Care in Catalonia: A Qualitative Study with Healthcare Professionals on the Management of Uncertainty and the Possibilities of Technological and Digital Developments.
    Healthcare (Basel). 2026;14:2928.
    PubMed    
    Abstract available
    
    

22. LI L, Zhao C, Wang F, Zhao Q, et al
    Irritable Bowel Syndrome and Incident Hypertension: Epidemiologic and Genetic Insights.
    Biomedicines. 2026;14:2057.
    PubMed    
    Abstract available
    
    

23. DUONG MA, Ramdass PVAK
    ATP-P2X3 Signaling as a Shared Neural Sensitization Pathway in Endometriosis and Irritable Bowel Syndrome: Mechanisms and Therapeutic Implications.
    Biomedicines. 2026;14:1891.
    PubMed    
    Abstract available
    
    

24. YANG W, Liu Y, Wang H, Yang G, et al
    Exercise and Intestinal Barrier Integrity: Molecular Mechanisms and Therapeutic Potential in Gut Health and Disease.
    Biology (Basel). 2026;15:1672.
    PubMed    
    Abstract available
    
    

25. ROUTHIAUX K, Van den Houte K, Balsiger L, Raymenants K, et al
    Avoidant/restrictive food intake across the gastrointestinal tract.
    Clin Gastroenterol Hepatol. 2026 Oct 9:S1542-3565(26)00743.
    PubMed    
    Abstract available
    
    

26. KIM JH, Park SJ, Huh CS, Shin CH, et al
    Lactiplantibacillus Plantarum CKDB008 and Lacticaseibacillus Rhamnosus LDTM7511 Attenuate Visceral Hypersensitivity and Suppress Serum IgE in an Acetic Acid-Induced IBS-Like Rat Model.
    Probiotics Antimicrob Proteins. 2026 Oct 9. doi: 10.1007/s12602-026-11238.
    PubMed    
    Abstract available
    
    

27. PAN L, Ran P, Jiang F, Wang Y, et al
    Role of Bile Acid Receptors in Non-Infectious Diarrhea: A Narrative Review.
    Med Sci Monit. 2026;32:e952723.
    PubMed    
    Abstract available
    
    

28. LI W, Zhang Z, Lu C, Xu Y, et al
    Frailty and risk of common chronic diseases among cancer survivors: a prospective cohort study.
    J Cancer Surviv. 2026 Oct 9. doi: 10.1007/s11764-026-02118.
    PubMed    
    Abstract available
    
    

29. HOD K, Marasco G, Colecchia L, Sperber AD, et al
    Life-course hygiene exposures and disorders of gut-brain interaction: a multinational cross-sectional study.
    Intern Emerg Med. 2026 Oct 8. doi: 10.1007/s11739-026-04546.
    PubMed    
    Abstract available
    
    

30. RUBING W, Jinying Z, Lingzu K, Xu F, et al
    Visualization analysis of research hotspots and trends in traditional Chinese medicine external therapies for irritable bowel syndrome.
    Front Med (Lausanne). 2026;13:1954763.
    PubMed    
    Abstract available
    
    

31. MIN JH, Jo YW, Her Y, Kwon JW, et al
    Gut-Skin Axis Revisited: A Nationwide Cohort Study on the Bi-directional Relationship Between Rosacea and Irritable Bowel Syndrome.
    Ann Dermatol. 2026;38:388-396.
    PubMed    
    Abstract available
    
    

32. TALEBI SS, Ahmadimoghaddam D, Mirjalili M, Keshavarzi A, et al
    Agomelatine improves symptom severity and quality of life in diarrhea-predominant irritable bowel syndrome: insights from a randomized controlled clinical trial.
    Naunyn Schmiedebergs Arch Pharmacol. 2026 Oct 8. doi: 10.1007/s00210-026-05975.
    PubMed    
    Abstract available
    
    

33. STALLER K, Goodoory VC, Khasawneh M, Black CJ, et al
    Validation of Rome V for irritable bowel syndrome - Authors' reply.
    Lancet Gastroenterol Hepatol. 2026;11:955-956.
    PubMed    
    
    
    

34. SIMREN M, Aziz I, Tack J
    Validation of Rome V for irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2026;11:954-955.
    PubMed    
    
    
    

35. NG DYL, Biesiekierski J, Hebbard G, Talley NJ, et al
    Validation of Rome V for irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2026;11:953-954.
    PubMed    
    
    
    

36. HASANUZZAMAN M, Bang CS, Lee JJ, Gong EJ, et al
    Fecal Microbiota Transplantation Beyond Clostridioides difficile Infection: Expanding Indications, Mechanisms, and Future Directions.
    J Korean Med Sci. 2026;41:e335.
    PubMed    
    Abstract available
    
    

37. GUADANO-PROCESI I, Garcia Ramos A, Gentekaki E, Tsaousis AD, et al
    Exploring Blastocystis: hidden complexity in a common intestinal microbe.
    J Med Microbiol. 2026;75:002198.
    PubMed    
    Abstract available
    
    

38. REZAZADEGAN M, Saneei P, Soheilipour M, Rezazadegan N, et al
    Co-supplementation of zinc and probiotic on oxidative stress markers and sleep quality index in irritable bowel syndrome patients: a double-blind randomized controlled trial.
    Eur J Nutr. 2026;65:273.
    PubMed    
    Abstract available
    
    

39. MONTGOMERY S, Saraga A, Rothschild NDV, Soliman MA, et al
    Irritable bowel syndrome-like symptoms are associated with increased healthcare utilization in patients with inflammatory bowel disease.
    Front Gastroenterol (Lausanne). 2026;5:1924176.
    PubMed    
    Abstract available
    
    

40. TIAN L, Bai Y, Wang S, Wang C, et al
    Codonopsis pilosula inulin-type fructan CPA ameliorates diarrhea-predominant irritable bowel syndrome via regulation of ER stress-induced autophagy and modulation of gut microbiota.
    Front Pharmacol. 2026;17:1715972.
    PubMed    
    Abstract available
    
    

41. BOSMAN M, Vork L, Van Den Houte M, van Oudenhove L, et al
    Real-time abdominal pain - daily life trigger associations in IBS: a multicenter Experience Sampling Method Study.
    Clin Gastroenterol Hepatol. 2026 Oct 6:S1542-3565(26)00747.
    PubMed    
    Abstract available
    
    

42. LIMAYE S, Bhide P, Kale A, Bokey N, et al
    SCFA Alterations in IBS Subtypes: Systematic Evidence and Future Prospects for Biomarker-Based Diagnosis in India.
    J Microbiol Biotechnol. 2026;36:e2605029.
    PubMed    
    Abstract available
    
    

43. ATEF M, Abdalaziz RA, Badry A, Darweesh H, et al
    The diagnostic utility of abdominal and bowel ultrasound in detecting gastrointestinal and hepatic manifestations of rheumatoid arthritis.
    Arab J Gastroenterol. 2026 Oct 5:S1687-1979(26)00116.
    PubMed    
    Abstract available
    
    

44. VAN VORSTENBOSCH R, Esenkova EE, Jonkers DMAE, Elizalde Vilalta M, et al
    Investigating the presence of microbiota-based phenotypes in Irritable Bowel Syndrome.
    J Breath Res. 2026 Oct 5. doi: 10.1088/1752-7163.
    PubMed    
    Abstract available
    
    

45. STALLER K, Clukey J, Madva EN, Healy BC, et al
    CYP2D6 Metabolizer Status Does Not Predict Response or Tolerability of Low-Dose Nortriptyline for Irritable Bowel Syndrome With Diarrhea.
    Gastro Hep Adv. 2026;5:101111.
    PubMed    
    
    
    

46. IBRAHIM I, Lawrence K, Forte OA, Huitt L, et al
    Diffuse Idiopathic Skeletal Hyperostosis (DISH): Potential Links Between Gut Microbiota and Spinal Degenerative Diseases.
    Nutrients. 2026;18:3168.
    PubMed    
    Abstract available
    
    

47. JENKINS SANCHEZ L, Poppe J, Baudot A, Vu LD, et al
    Impact of Triacetin- and Tributyrin-Based Formulations on IBS Microbiome Composition and SCFA Profiles: A Preclinical Study.
    Int J Mol Sci. 2026;27:8910.
    PubMed    
    Abstract available
    
    

48. BEAUDEAU J, Escudero-Hernandez C, Abruzzese V, Katinios G, et al
    Differential Enteric Glial and Mast Cell Characteristics Distinguish Microscopic Colitis Subtypes Relative to Healthy and Disease Controls, with Treatment-Associated Reductions in Glial Reactivity and Mast Cell Degranulation in Collagenous Colitis.
    Cells. 2026;15:1778.
    PubMed    
    Abstract available
    
    

49. BOZKURT E, Saglam O, Sari A, Ay M, et al
    Pathogen and Testing Profiles in Post-Infectious Irritable Bowel Syndrome Across the COVID-19 Public Health Emergency: A Retrospective Case Series.
    J Clin Med. 2026;15:7729.
    PubMed    
    Abstract available
    
    

50. SCHNEDL WJ, Michaelis S, Schenk M, Enko D, et al
    Food intolerance/malabsorption in Hashimoto's thyroiditis.
    Clinics (Sao Paulo). 2026;81:101168.
    PubMed    
    Abstract available
    
    

51. RUFA AP, Dolphin MR, Adams KR
    Prevalence, Incidence, and Associated Conditions of Complex Regional Pain Syndrome in a Large Real-World Dataset.
    J Pain Res. 2026;19:612185.
    PubMed    
    Abstract available
    
    

52. LIU N, Huang Y, Qiao H, Wang Y, et al
    A meta-analysis of berberine combined with brain-gut axis-targeted agents for diarrhoea-predominant irritable bowel syndrome.
    Front Pharmacol. 2026;17:1795170.
    PubMed    
    Abstract available
    
    

53. CHANG L, Freimer NB, Hsiao EY
    The Brain-Gut-Microbiome Axis: Exploring the Link Between Depression and Irritable Bowel Syndrome.
    Annu Rev Physiol. 2026 Oct 14. doi: 10.1146/annurev-physiol-040225-111420.
    PubMed    
    Abstract available
    
    

54. CHU CC, Lin YT, Wang JJ
    Nociplastic Pain: A Contemporary Narrative Review of Mechanisms, Clinical Assessment, Controversies, and Management.
    J Pain Res. 2026;19:642440.
    PubMed    
    Abstract available
    
    

55. LI L, Long Q, Tan Z, Deng N, et al
    Therapeutic potential of Sishen Pill: modulating intestinal mucosal microbiota and barrier function in diarrhea-predominant irritable bowel syndrome with Spleen-Kidney Yang Deficiency.
    Biosci Microbiota Food Health. 2026;45:237-253.
    PubMed    
    Abstract available
    
    

56. FLYNN KJ, Ransom JT, McGrath D
    A trial of exosome rich stem cell secretome as a potential treatment for Hypermobile Ehlers-Danlos Syndrome.
    Front Med (Lausanne). 2026;13:1945865.
    PubMed    
    Abstract available
    
    

57. FIRDOUS J, Khan RMU, Jabeen F, Inayat A, et al
    Irritable bowel syndrome and restless legs syndrome: a narrative review of epidemiological and pathophysiological overlap.
    Ann Med Surg (Lond). 2026;88:6606-6617.
    PubMed    
    Abstract available
    
    

58. ABDEL-MAGID AF
    Novel Treatment of Irritable Bowel Syndrome (IBS) and Other Disorders of the Peripheral Nervous System Using Peripherally Restricted Positive Allosteric Modulators of GABA?A Receptor.
    ACS Med Chem Lett. 2026;17:2114-2116.
    PubMed    
    Abstract available
    
    

59. XIE P, Luo M, Fan J, Xiong L, et al
    A global atlas of the gut virome reveals subtype-specific and functional alterations in irritable bowel syndrome.
    mSystems. 2026 Oct 12:e0090126. doi: 10.1128/msystems.00901.
    PubMed    
    Abstract available
    
    

60. VON MUHLENBROCK C, Carbone F, Van de Bruaene C, Balsiger LM, et al
    Global IBS, Local Patterns: Regional Variability in Pain, Bloating, and Impact on Daily Life Among Asian/Australian and European Patients From the Aegis Epidemiology Survey.
    Neurogastroenterol Motil. 2026;38:e70453.
    PubMed    
    Abstract available
    
    

61. 
    Correction to "Deciphering Gut Microbiome Dynamics in Irritable Bowel Syndrome Using Deep Learning".
    Neurogastroenterol Motil. 2026;38:e70445.
    PubMed    
    
    
    

62. KATSUMATA R, Storsrud S, Simren M, Nybacka S, et al
    Development and Validation of the Food Expectation Questionnaire (FEX-Q): An Image-Based Instrument to Assess Food-Related Perceptions and Symptom Expectations.
    Neurogastroenterol Motil. 2026;38:e70464.
    PubMed    
    Abstract available
    
    

63. MORSY SM, Abdeltawab MSA, Mahfoz AM, Elkerdawy MA, et al
    Association of Blastocystis subtype 3 with elevated IL-8-mediated inflammation in patients with irritable bowel syndrome.
    Gut Pathog. 2026;18:82.
    PubMed    
    Abstract available
    
    

64. BAI X, Jing Y, Wang Y, Hao Y, et al
    High CLA-producing Lactiplantibacillus plantarum MNN1 alleviates irritable bowel syndrome through activation of intestinal PPARalpha signaling pathway.
    Food Res Int. 2026;245.
    PubMed    
    Abstract available
    
    

65. LI G, Lin J, Tang S, Wang Y, et al
    Multivariate GWAS Analysis Reveals a Common Genetic Factor Linking Dry Eye Disease to Gastrointestinal Comorbidities.
    Transl Vis Sci Technol. 2026;15:32.
    PubMed    
    Abstract available
    
    

66. YAMAKAWA T, Hara T, Wagatsuma K, Yamamoto S, et al
    Clinical Performance of Fecal Calprotectin Reagents Based on the Colloidal Gold Agglutination Method for Evaluating the Differential Diagnosis between Inflammatory Bowel Disease and Irritable Bowel Syndrome in Adults and Children with Gastrointestinal
    Inflamm Intest Dis. 2026;11:393-405.
    PubMed    
    Abstract available
    
    

67. HAMMERSMITH AR, Yunusa I, Cai C, Love BL, et al
    Eluxadoline Utilization in Medicare Part D, 2016-23: National Trends, Geographic Variation, Prescriber-Type Patterns, and Spending.
    Drugs Real World Outcomes. 2026 Oct 23. doi: 10.1007/s40801-026-00587.
    PubMed    
    Abstract available
    
    

68. BILICAN G, Brezina B, Sharip MT, Subramanian S, et al
    Pitfalls in the Diagnosis and Classification of Crohn's Disease: Misdiagnosis, Overdiagnosis, and Misclassification.
    Turk J Gastroenterol. 2026 Oct 6. doi: 10.5152/tjg.2026.26534.
    PubMed    
    Abstract available
    
    

69. MA J, Chen Y, Xia Y
    [Explanation on modern mechanism of "for abdominal-diseases, Zusanli is indicated": acupuncture at Zusanli (ST36) regulates the brain-gut "neuro-immune axis" for the treatment of diarrhea-predominant irritable bowel syndrome].
    Zhen Ci Yan Jiu. 2026;51:1367-1375.
    PubMed    
    Abstract available
    
    

70. QIAN S, Zhang L, Zhang J, Cui G, et al
    [Comparative study on intervention effects of electroacupuncture at single point "Zusanli" (ST36), "Sanyinjiao" (SP6) and combined points on irritable bowel syndrome mice].
    Zhen Ci Yan Jiu. 2026;51:1282-1296.
    PubMed    
    Abstract available
    
    

71. HIGASHIYAMA M, Kurihara C, Shiotani A, Mizukami T, et al
    Biopsy-Confirmed Serofrequency of Celiac Disease among Patients with Disorders of Gut-Brain Interaction in Japan: A Multicenter Cross-Sectional Cohort Study.
    Inflamm Intest Dis. 2026;11:429-435.
    PubMed    
    Abstract available
    
    

72. CAO B, Zhou L, Hu S, Huang Y, et al
    Evidence consistency analysis of the effect of a low-FODMAP diet on the abundance of Bifidobacterium and Faecalibacterium prausnitzii in patients with irritable bowel syndrome.
    Front Microbiol. 2026;17:1948754.
    PubMed    
    Abstract available
    
    

73. HOWELL CA, Nair MV, Auth MK, Spray C, et al
    Randomised, placebo-controlled study to assess the safety and efficacy of Enterosgel(R) in the treatment of functional abdominal pain in children and young people (ENTOPIC): study protocol for a clinical trial.
    Trials. 2026;27:618.
    PubMed    
    Abstract available
    
    

74. ZHENG SH, Gao SJ, Cai JJ, Shen ZX, et al
    Beyond the pelvis: redefining endometriosis as a systemic inflammatory disorder. A systematic review and meta-analysis.
    Autoimmun Rev. 2026 Oct 20:104206. doi: 10.1016/j.autrev.2026.104206.
    PubMed    
    Abstract available
    
    

75. YU LC, Huang CY, Lin CY, Tsai YS, et al
    Maladaptive sensory coding in the enteric nervous system playing a role in gastrointestinal disorders.
    Front Cell Neurosci. 2026;20:1903390.
    PubMed    
    Abstract available
    
    

76. WANG J, Chen X, Tong S, Qu C, et al
    TRPV4/NCX1 coupling regulates Ca(2+)-dependent cholecystokinin secretion from enteroendocrine cells to involve the pathogenesis of irritable bowel syndrome-diarrhea in male mice.
    Physiol Rep. 2026;14:e71149.
    PubMed    
    Abstract available
    
    

77. DIAZ-MUNOZ C, Broeders B, Bonfiglio F, Zamfir-Taranu A, et al
    A Genome-Wide Meta-Analysis of Functional Dyspepsia in 1,168,899 Individuals Implicates Immune Pathways in Disease Susceptibility.
    Neurogastroenterol Motil. 2026;38:e70469.
    PubMed    
    Abstract available
    
    

78. JIANG X, He W, Xu C, Zheng W, et al
    Monocyte surface Y RNAs potentiate innate immunity.
    Nat Cell Biol. 2026 Oct 19. doi: 10.1038/s41556-026-02100.
    PubMed    
    Abstract available
    
    

79. GAILOT A, Banihani N, Muhammad N
    Beyond the Bowel: A Narrative Review Examining Bidirectional Mental Health Pathways Across Disorders of Gut-Brain Interaction and Inflammatory Bowel Disease.
    Cureus. 2026;18:e116451.
    PubMed    
    Abstract available
    
    

80. KOPCZYNSKA M, Durko L, Caban M, Malecka-Wojciesko E, et al
    Correlation between severity of depression and quality of life in irritable bowel syndrome.
    Prz Gastroenterol. 2026;21:319-326.
    PubMed    
    Abstract available
    
    

81. BIANCO A, Verrelli N, Riezzo G, Laselva G, et al
    Clinical, functional, and quality-of-life characteristics of women with comorbid fibromyalgia and irritable bowel syndrome and their associations with FIQR scores.
    Front Physiol. 2026;17:1922718.
    PubMed    
    Abstract available
    
    

82. VAN GILS T, Tornblom H, van Overveld F, Palsson OS, et al
    Symptom Profiles Compatible With Disorders of Gut-Brain Interaction in Individuals With Coeliac Disease on a Long-Term Gluten-Free Diet.
    United European Gastroenterol J. 2026;14:e70311.
    PubMed    
    Abstract available
    
    

83. ZHANG Z, Wu R, Liu F, Chen S, et al
    Exploring the Potential Mechanism of Zhizhu Decoction in the Treatment of Constipation-Predominant Irritable Bowel Syndrome Through Network Pharmacology and Experimental Validation.
    Biol Proced Online. 2026;28:41.
    PubMed    
    Abstract available
    
    

84. WANG PF
    Letter: Timing Matters-Interpreting Colonic Gas Reduction With Gel-Forming Fibres.
    Aliment Pharmacol Ther. 2026 Sep 27. doi: 10.1111/apt.71023.
    PubMed    
    
    
    

85. SHAH E, Lacy B, Williams L, Yang Y, et al
    Efficacy of Tenapanor in Patients With or Without Prior Use of IBS-C Prescription Medications: A Post-hoc Analysis of Phase 3 Clinical Trials.
    Dig Dis Sci. 2026 Oct 11. doi: 10.1007/s10620-026-10273.
    PubMed    
    Abstract available
    
    

86. ROSSI RE, Masoni B, Migliorisi G, Policane M, et al
    PREVALENCE OF DISORDERS OF GUT-BRAIN INTERACTION IN TREATED CELIAC DISEASE: A SYSTEMATIC REVIEW.
    Clin Res Hepatol Gastroenterol. 2026 Oct 23:102953.
    PubMed    
    Abstract available
    
    

87. AKBARI HHA, Mokhtari A
    The Effectiveness of Emotion Regulation-Based Therapy on Emotion Regulation, Cognitive Flexibility, and Symptom Severity in Patients with Irritable Bowel Syndrome.
    Clin Res Hepatol Gastroenterol. 2026 Oct 20:102945.
    PubMed    
    Abstract available
    
    

88. CAMILLERI M, Ford AC
    Potential for GLP-1 Receptor Agonists in Irritable Bowel Syndrome.
    Gastroenterology. 2026 Oct 23:S0016-5085(26)07731.
    PubMed    
    
    
    

89. SHIHA MG, Aziz I
    Irritable bowel syndrome and suicide risk.
    Gastroenterology. 2026 Oct 21:S0016-5085(26)07730.
    PubMed    
    
    
    

90. PERERA P, Wickramasinghe D, Wannakuwatta R, Wickramasinghe DP, et al
    Bowel habits and functional bowel disorders in Sri Lankan adults: A cross-sectional study.
    Indian J Gastroenterol. 2026 Sep 25. doi: 10.1007/s12664-026-02049.
    PubMed    
    Abstract available
    
    

91. RAMISCH M, Benz-Sahnoun S, Guenther V, Korn A, et al
    Personalized psychotherapy in irritable bowel syndrome: results from a pilot randomized controlled trial (PIONEER-IBS).
    J Psychosom Res. 2026;211:113003.
    PubMed    
    Abstract available